GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15411649

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

GLP-2 analogues are disclosed which comprise one of more substitutions as compared to [hGly2]GLP-2 and which improved biological activity in vivo and/or improved chemical stability, e.g., as assessed in in vitro stability assays. More particularly, preferred GLP-2 analogues disclosed herein comprise substitutions at one or more of positions 8, 16, 24 and/or 28 of the wild-type GLP-2 sequence, optionally in combination with further substitutions at position 2 (as mentioned in the introduction) and one or more of positions 3, 5, 7, 10 and 11, and/or a deletion of one or more of amino acids 31 to 33 and/or the addition of a N-terminal or C-terminal stabilizing peptide sequence. The analogues are particularly useful for the prophylaxis or treatment of stomach and bowel-related disorders and for ameliorating side effects of chemotherapy. Also disclosed are methods and kits for selecting a patient from populations suited for treatment with GLP-2 analogues.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ZEALAND PHARMA A/SSMEDELAND 36 GLOSTRUP DK-2600

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
LARSEN, Bjarne Due Roskilde, DK 69 1486
Petersen, Yvette Miata Bagsvaerd, DK 11 166

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation